PT Suparma Tbk Income Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,740,742	2,729,636	2,658,521	3,138,054	2,794,453
Revenue Growth (YoY)	0.41%	2.67%	-15.28%	12.30%	29.88%
Cost of Revenue	2,306,307	2,324,167	2,196,750	2,427,849	2,212,061
Gross Profit	434,435	405,469	461,771	710,205	582,392
Selling, General & Admin	230,651	209,905	206,708	183,723	169,709
Other Operating Expenses	6,170	5,228	-	613.51	-
Operating Expenses	236,822	215,133	206,708	184,337	169,709
Operating Income	197,613	190,336	255,063	525,868	412,683
Interest Expense	-44,767	-35,208	-34,876	-32,682	-31,355
Interest & Investment Income	-	7,541	5,809	4,247	1,344
Currency Exchange Gain (Loss)	-23,929	-29,452	9,086	-65,997	335.94
Other Non Operating Income (Expenses)	7,821	-3,424	3,042	632.25	3,373
EBT Excluding Unusual Items	136,737	129,793	238,124	432,068	386,381
Gain (Loss) on Sale of Investments	-	4,650	-461.94	-622.47	-
Gain (Loss) on Sale of Assets	-	-	186.72	-	-
Other Unusual Items	-	-	-	-	-8,871
Pretax Income	136,737	134,443	237,849	431,446	377,510
Income Tax Expense	30,507	29,604	59,190	95,308	83,184
Net Income	106,231	104,839	178,658	336,138	294,326
Net Income to Common	106,231	104,839	178,658	336,138	294,326
Net Income Growth	1.33%	-41.32%	-46.85%	14.21%	81.10%
Shares Outstanding (Basic)	4,086	4,100	4,100	4,100	4,100
Shares Outstanding (Diluted)	4,086	4,100	4,100	4,100	4,100
Shares Change (YoY)	-0.35%	-	-	-	-
EPS (Basic)	26.00	25.57	43.57	81.98	71.78
EPS (Diluted)	26.00	25.57	43.57	81.98	71.78
EPS Growth	1.69%	-41.32%	-46.85%	14.21%	81.10%
Free Cash Flow	542,722	671,488	654,950	862,153	744,770
Free Cash Flow Per Share	132.83	163.76	159.73	210.26	181.64
Dividend Per Share	-	-	9.231	-	-
Gross Margin	15.85%	14.85%	17.37%	22.63%	20.84%
Operating Margin	7.21%	6.97%	9.59%	16.76%	14.77%
Profit Margin	3.88%	3.84%	6.72%	10.71%	10.53%
Free Cash Flow Margin	19.80%	24.60%	24.64%	27.47%	26.65%
EBITDA	343,001	299,377	352,014	616,613	493,098
EBITDA Margin	12.52%	10.97%	13.24%	19.65%	17.65%
D&A For EBITDA	145,388	109,041	96,951	90,745	80,415
EBIT	197,613	190,336	255,063	525,868	412,683
EBIT Margin	7.21%	6.97%	9.59%	16.76%	14.77%
Effective Tax Rate	22.31%	22.02%	24.89%	22.09%	22.04%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.